unknown
Stage
About
AbbraTech develops a recombinant antibody discovery platform that enables the identification and engineering of antibodies against challenging disease targets using its EPIVOLVEsm technology.
Explore AbbraTech's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.